FGC
IMMU

Financial Gravity Companies’s Immunomedics Inc IMMU Stock Holding History

Financial Gravity Companies’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$0 Buy
+19
New +$377 ﹤0.01% 1573

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Financial Gravity Companies's IMMU Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Immunomedics Inc (IMMU) in Q4 2018: 19 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1573 among its holdings.

205 funds tracked by Wall St. Rank hold IMMU as of Q4 2018.

  • Financial Gravity Companies held 19 shares of Immunomedics Inc worth $0 as of Q4 2018.
  • Immunomedics Inc was a new Financial Gravity Companies position in Q4 2018.
  • Immunomedics Inc made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1573 holding.
  • 205 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.